Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
K-12 Science Teachers and Parents Also Agree Outside Mentors and Use of Technology Resources Can Play an Important Role CHICAGO AND DEERFIELD, IL, October 28, 2010 – A new national survey...
Phase IV Data Meets Primary Endpoint PHILADELPHIA, PA, September 25, 2010 – Today Astellas Pharma US, Inc., (“Astellas”) announced results of a Phase IV study showing Lexiscan®...
PHILADELPHIA, PA, September 24, 2010 - Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for...
Read more about New Smartphone App Launches For Cardiac Imaging Test
DEERFIELD, IL, September 15, 2010 – Astellas Pharma US, Inc. has announced the winners of the second 2010 Transplant Scholars Awards, which awarded a dozen $5,000 educational scholarships to...
SANTA MONICA, Calif.- Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate...
Follow U.S. news
